Sartorius AG is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging ...

The Sartorius AG logo can be seen on the company's building. Swen Pförtner/dpa German pharma and lab supplier Sartorius reported that fiscal 2023 profit to equity holders of Sartorius AG declined to ...

Sartorius announced the 2.4 billion euro acquisition of Polyplus. Polyplus is producing transfection reagents and generates 100 million euros in revenues. The acquisition appears to be very expensive ...

GOTTINGEN, Germany - March 27, 2025 (NEWMEDIAWIRE) - The life science group Sartorius held its virtual Annual General Meeting today. The shareholders approved all proposals of the Supervisory Board ...

GOTTINGEN, Germany--(BUSINESS WIRE)--At today’s Annual Shareholders’ Meeting of Sartorius AG in Göttingen, Germany, shareholders approved the board's proposals by a large majority. The Annual ...

SARTORIUS AG (SARTF) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.66 per share a year ago. These ...

GÖTTINGEN, Germany, Oct. 13, 2021 /PRNewswire/ -- Karin Sartorius-Herbst and LifeScience Holding SCSp ("LSH") have entered into option agreements to acquire a total portion of approximately 56.7 ...

Management at wide-moat companies Sartorius AG SRT3 and its bioprocessing subsidiary Sartorius Stedim DIM significantly reduced 2023 guidance, as demand for their life science tools have softened in ...

Feb 25 (Reuters) - Laboratory supplies vendor Sartorius AG (SATG.DE), opens new tab has approached Maravai LifeSciences Holdings Inc (MRVI.O), opens new tab, a U.S. provider of capping reagents for ...

The positions in the table below reflect the Sartorius AG's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...